Medicare Enrolled
Dr. Andrew Weber, MD
Hematology · Panama City, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Weber from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Weber? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Weber
Dr. Andrew Weber is a hematology in Panama City, FL, with 17 years in practice. Based on federal Medicare data, Dr. Weber performed 396,759 Medicare services across 10,553 unique beneficiaries.
Between the years covered by Open Payments, Dr. Weber received a total of $17,545 from 96 pharmaceutical and/or device companies across 988 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Weber is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 17 years in practice▲ Top 3% volume in FL$ $17,545 industry payments
Medicare Practice Summary
Medicare Utilization ↗396,759
Medicare services
Top 3% in FL for hematology
10,553
Unique beneficiaries
$11
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~23,339 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Darbepoetin injection (Aranesp) for anemia | 69,900 | $2 | $21 |
| Filgrastim injection (Zarxio) for white blood cells | 65,340 | $0 | $2 |
| Nivolumab injection (Opdivo) | 42,180 | $23 | $82 |
| Anti-nausea injection (fosaprepitant) | 31,650 | $0 | $6 |
| Pembrolizumab injection (Keytruda) | 26,600 | $43 | $146 |
| Denosumab injection (Prolia/Xgeva) | 26,040 | $18 | $70 |
| Iron infusion (Injectafer) | 23,250 | $1 | $5 |
| Iron infusion (Monoferric) | 17,200 | $17 | $75 |
| Daratumumab injection (Darzalex) | 14,760 | $38 | $136 |
| Paclitaxel chemotherapy injection | 14,306 | $0 | $1 |
| Contrast dye for imaging (iodine-based) | 6,215 | $0 | $3 |
| Epoetin alfa injection (Procrit) for anemia | 6,040 | $6 | $55 |
| Injection, bevacizumab-bvzr, biosimilar, (zirabev), 10 mg | 6,040 | $23 | $166 |
| Dexamethasone injection (steroid) | 5,130 | $0 | $1 |
| Complete blood count (CBC) with differential | 4,929 | $8 | $35 |
| Blood draw (venipuncture) | 4,268 | $8 | $19 |
| Comprehensive metabolic blood panel | 3,987 | $10 | $62 |
| Anti-nausea injection (Aloxi/palonosetron) | 3,370 | $1 | $122 |
| Injection, granisetron hydrochloride, 100 mcg | 2,420 | $0 | $25 |
| Injection, fulvestrant, 25 mg | 2,000 | $8 | $262 |
| Office visit, established patient (30-39 min) | 1,844 | $89 | $224 |
| Injection, leucovorin calcium, per 50 mg | 1,548 | $3 | $27 |
| Iron level test | 1,527 | $6 | $26 |
| Ferritin level test (iron stores) | 1,525 | $13 | $58 |
| Iron binding capacity test | 1,525 | $9 | $34 |
| Injection of additional new drug or substance into vein | 1,252 | $12 | $105 |
| Drug injection, under skin or into muscle | 1,073 | $10 | $93 |
| Administration of chemotherapy into vein, 1 hour or less | 1,061 | $98 | $686 |
| Office visit, established patient (20-29 min) | 1,024 | $68 | $148 |
| Injection, fluorouracil, 500 mg | 932 | $2 | $14 |
| Injection, magnesium sulfate, per 500 mg | 864 | $1 | $6 |
| Antibody identification test, platelet associated immunoglobulin assay | 814 | $12 | $155 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 752 | $22 | $152 |
| Lactate dehydrogenase (enzyme) level | 697 | $6 | $30 |
| Injection, carboplatin, 50 mg | 423 | $2 | $300 |
| Injection, diphenhydramine hcl, up to 50 mg | 411 | $1 | $7 |
| Anti-nausea injection (ondansetron/Zofran) | 356 | $0 | $3 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 340 | $47 | $304 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 328 | $54 | $205 |
| Administration of additional new drug or substance into vein, 1 hour or less | 320 | $50 | $334 |
| Magnesium level test | 293 | $7 | $28 |
| New patient office visit, complex (60-74 min) | 264 | $161 | $432 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 263 | $16 | $97 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 235 | $25 | $141 |
| Administration of chemotherapy into vein, each additional hour | 199 | $22 | $156 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 166 | $1 | $19 |
| Unclassified drugs | 161 | $1 | $9 |
| Infusion, normal saline solution , 1000 cc | 152 | $2 | $19 |
| Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l | 111 | $132 | $986 |
| Irrigation of implanted venous access drug delivery device | 86 | $19 | $111 |
| Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion | 69 | $15 | $91 |
| Initial hospital admission, high complexity | 69 | $140 | $412 |
| Urinalysis, manual | 61 | $3 | $15 |
| Ct scan of chest with contrast | 56 | $86 | $1,005 |
| Infusion into a vein for hydration, 31-60 minutes | 51 | $25 | $249 |
| Uric acid level test | 45 | $4 | $24 |
| CT scan of abdomen and pelvis with contrast | 43 | $218 | $1,400 |
| Infusion into a vein for hydration, each additional hour | 35 | $10 | $73 |
| Office visit, established patient, complex (40-54 min) | 34 | $126 | $301 |
| Administration of additional new drug or substance into vein using push technique | 30 | $41 | $281 |
| Biopsy and aspiration of bone marrow sample for diagnosis | 25 | $122 | $523 |
| Injection of drug or substance into vein | 25 | $29 | $240 |
| Blood creatinine level | 18 | $5 | $30 |
| Hospital follow-up visit, high complexity | 15 | $96 | $232 |
| Infusion, normal saline solution, sterile (500 ml = 1 unit) | 12 | $1 | $19 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
10.6% high complexity
83.4% medium
5.9% routine
Industry Payment Transparency
Open Payments through 2024 ↗$17,545
Total received (2018-2024)
Avg $2,506/year across 7 years
Top 28% in FL for hematology
96
Companies
988
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$17,472 (99.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$73 (0.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$3,201
2023$2,962
2022$2,784
2021$2,827
2020$2,221
2019$2,300
2018$1,251
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$2,049
AstraZeneca Pharmaceuticals LP
$1,115
Janssen Biotech, Inc.
$983
Amgen Inc.
$970
E.R. Squibb & Sons, L.L.C.
$846
Celgene Corporation
$844
Regeneron Healthcare Solutions, Inc.
$829
GENZYME CORPORATION
$581
Daiichi Sankyo Inc.
$504
Genentech USA, Inc.
$502
Merck Sharp & Dohme Corporation
$467
PFIZER INC.
$411
Ipsen Biopharmaceuticals, Inc
$394
Incyte Corporation
$335
Lilly USA, LLC
$322
BeiGene USA, Inc.
$314
Eisai Inc.
$312
Octapharma USA, Inc.
$303
Merck Sharp & Dohme LLC
$293
GlaxoSmithKline, LLC.
$267
Blueprint Medicines Corporation
$234
Takeda Pharmaceuticals U.S.A., Inc.
$215
Astellas Pharma US Inc
$208
Bayer HealthCare Pharmaceuticals Inc.
$191
Exelixis Inc.
$170
Gilead Sciences, Inc.
$161
Pharmacyclics LLC, An AbbVie Company
$148
ARRAY BIOPHARMA INC
$145
EISAI INC.
$143
Foundation Medicine, Inc.
$129
Boehringer Ingelheim Pharmaceuticals, Inc.
$124
ABBVIE INC.
$123
Seagen Inc.
$123
Karyopharm Therapeutics Inc.
$119
Stemline Therapeutics Inc.
$118
AbbVie, Inc.
$108
Coherus Biosciences Inc.
$104
Taiho Oncology, Inc.
$99
AVEO Pharmaceuticals, Inc.
$87
Puma Biotechnology, Inc.
$85
Bayer Healthcare Pharmaceuticals Inc.
$81
JAZZ PHARMACEUTICALS INC.
$77
Pharmacyclics LLC, an AbbVie Company
$77
Dendreon Pharmaceuticals LLC
$69
Rigel Pharmaceuticals, Inc.
$67
Global Blood Therapeutics, Inc.
$66
Deciphera Pharmaceuticals Inc.
$65
Apellis Pharmaceuticals, Inc.
$63
Mirati Therapeutics, Inc.
$63
Janssen Pharmaceuticals, Inc
$60
Teva Pharmaceuticals USA, Inc.
$59
Pharmacosmos Therapeutics Inc.
$59
Progenics Pharmaceuticals, Inc.
$58
AbbVie Inc.
$57
G1 Therapeutics, Inc.
$55
Aveo Pharmaceuticals, Inc.
$54
EMD Serono, Inc.
$53
SpringWorks Therapeutics, Inc.
$53
Myriad Genetic Laboratories, Inc.
$53
TerSera Therapeutics LLC
$52
Acceleron Pharma, Inc.
$49
PUMA BIOTECHNOLOGY, INC.
$41
CSL Behring
$41
Kite Pharma, Inc.
$38
Alexion Pharmaceuticals, Inc.
$38
Secura Bio, Inc.
$36
Aurobindo Pharma USA, Inc.
$31
Lexicon Pharmaceuticals, Inc.
$30
Dova Pharmaceuticals
$30
Kyowa Kirin, Inc.
$28
Heron Therapeutics, Inc.
$27
INSYS Therapeutics Inc
$27
Adaptive Biotechnologies Corporation
$26
Clovis Oncology, Inc.
$25
Emmaus Medical, Inc.
$23
AMAG Pharmaceuticals, Inc.
$23
Sun Pharmaceutical Industries Inc.
$21
Jazz Pharmaceuticals Inc.
$20
SOBI, INC
$18
PROGENICS PHARMACEUTICALS, INC.
$18
Genmab U.S., Inc.
$18
Novocure Inc.
$18
Spectrum Pharmaceuticals Inc.
$17
TG Therapeutics, Inc.
$17
Acrotech Biopharma Inc.
$16
Agios Pharmaceuticals, Inc.
$16
SERVIER PHARMACEUTICALS LLC
$15
Helsinn Therapeutics (U.S.), Inc.
$15
Alnylam Pharmaceuticals Inc.
$15
Immunocore Limited
$15
Sumitomo Pharma America, Inc.
$14
TESARO, Inc.
$14
MorphoSys, US Inc.
$13
ADC Therapeutics America, Inc.
$13
Epizyme, Inc.,
$12
Verastem, Inc.
$11
Top 3 companies account for 23.6% of total payments
Associated products mentioned in payments ›
ADAKVEO · ADCETRIS · AFINITOR · ALIMTA · AYVAKIT · Alecensa · Aliqopa · Aranesp · BELEODAQ · BENDEKA · BLENREP · BOSULIF · BRACAnalysis · BRAFTOVI · BRUKINSA · Beleodaq · CABLIVI · CABOMETYX · CALQUENCE · CARVYKTI · CINVANTI · COSELA · CYRAMZA · Cabometyx · Columvi · Copiktra · DARZALEX · Doptelet · ELAHERE · ELITEK · ELZONRIS · EMPLICITI · ENHERTU · ENJAYMO · EPKINLY · ERLEADA · Empaveli · Endari · Enhertu · Epkinly · Erivedge · Erleada · FARYDAK · FERAHEME · FOTIVDA · FOUNDATIONONE · FOUNDATIONONE CDX · Fabhalta · Farydak · Folotyn · GAVRETO · GAZYVA · GILOTRIF · IBRANCE · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INQOVI · INREBIC · Idelvion · Imbruvica · Inrebic · JAKAFI · JEMPERLI · JEVTANA · KANJINTI · KEYTRUDA · KIMMTRAK · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · Lunsumio · MEKINIST · MONJUVI · MONOFERRIC · MYRISK · Monoferric · NERLYNX · NINLARO · Nerlynx · Neulasta · Nexavar · Nplate · Nubeqa · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OGSIVEO · OJJAARA · ONPATTRO · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · OXBRYTA · Onivyde · Optune · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · POTELIGEO · PROMACTA · PROVENGE · PYLARIFY · Padcev · Perjeta · Phesgo · Pomalyst · Prolia · QINLOCK · Quzyttir · REBLOZYL · ROLVEDON · RYBREVANT · RYDAPT · Reblozyl · Rezlidhia · Rubraca · SANDOSTATIN · SARCLISA · SCEMBLIX · SHINGRIX · SOMATULINE DEPOT · SPRYCEL · SUBSYS · Somatuline Depot · Stivarga · TAFINLAR · TAGRISSO · TASIGNA · TAZVERIK · TECENTRIQ · TECVAYLI · TIBSOVO · TIVDAK · TUKYSA · Tavalisse · Tecentriq · Trodelvy · UKONIQ · ULTOMIRIS · Udenyca · VALCHLOR · VENCLEXTA · VERZENIO · Vectibix · Venclexta · Vyloy · XALKORI · XARELTO · XGEVA · XPOVIO · XTANDI · Xermelo · Xofigo · Xospata · YONSA · ZEJULA · ZEPZELCA · clonoSEQ · myRisk
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $4 per 100 Medicare services performed
Geographic Context
Hematologys within 10 mi
1
Per 100K population
0.6
County median income
$70,188
Nearest hospital
ASCENSION SACRED HEART BAY
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Weber is a mixed practice specialist, with above-average Medicare volume (top 3% in FL), and low-engagement industry engagement, with 17 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Weber experienced with darbepoetin injection (aranesp) for anemia?
Based on Medicare claims data, Dr. Weber performed 69,900 darbepoetin injection (aranesp) for anemia services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Weber receive payments from pharmaceutical companies?
Yes. Dr. Weber received a total of $17,545 from 96 companies across 988 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Weber's costs compare to other hematologys in Panama City?
Dr. Weber's average Medicare payment per service is $11. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Weber) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematologys in Panama City
Browse hematologys in Panama City ranked by procedure volume and transparency data.
Highest volume
Top Hematologys in FL
Hematologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematologys in FL
Which FL hematologys receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology